Prominent response to platinum‐based chemotherapy in a patient with BRCA2 mutant‐neuroendocrine prostate cancer and MDM2 amplification

INTRODUCTION: Genomic profiling provides useful information for diagnosis, treatment, and prognosis, and detection of certain defects, such as DNA repair gene aberrations or microsatellite instability, can possibly lead to optimal treatment, but this testing has not been widely used to inform prosta...

Descripción completa

Detalles Bibliográficos
Autores principales: Daimon, Tatsuaki, Kosaka, Takeo, Hongo, Hiroshi, Aimono, Eriko, Nakamura, Kohei, Mikami, Shuji, Nishihara, Hiroshi, Oya, Mototsugu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255288/
https://www.ncbi.nlm.nih.gov/pubmed/34258530
http://dx.doi.org/10.1002/iju5.12287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255288/
https://www.ncbi.nlm.nih.gov/pubmed/34258530
http://dx.doi.org/10.1002/iju5.12287

Ejemplares similares